<DOC>
	<DOCNO>NCT02673255</DOCNO>
	<brief_summary>Many plasma donation center Tetanus immunization program implement order collect plasma high level tetanus antibody . The immunization program require participant receive multiple tetanus vaccination period time goal hyper-immunizing tetanus . Their antibody-rich plasma use manufacture tetanus immunoglobulin product help prophylaxis treatment tetanus disease . The Tetanus vaccine previously use program longer manufacture . Therefore , must evaluate safety efficacy different vaccine use purpose . The FDA approve Tetanus vaccine currently available adult US combination vaccine also immunize Diphtheria and/or Pertussis . In study , investigator evaluate two vaccine combination Tetanus Diphtheria ( Td ) . Investigators evaluate vaccine contain Pertussis antigen . The vaccine evaluate manufactured MassBiologics Sanofi Pasteur ( Tenivac ) . The package insert vaccine indicate administer previously vaccinate people every 10 year . However , study evaluate whether safe effective dosing every 90 day . The investigator hypothesize least 25 % study subject positive response least one five plan dos . Each vaccine evaluate separately .</brief_summary>
	<brief_title>Safety Efficacy Two Tetanus-Diphtheria Vaccines Donor Hyper Immunization Program</brief_title>
	<detailed_description />
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female ≥18* year age Visit 1 . 2 . Subject meet suitability criterion would allow donation Normal Source Plasma donor 3 . Subject immunized tetanus within prior three ( 3 ) month 4 . Subject participate immunization program 5 . Subject posse preexist antibody tetanus least 0.15 IU/mL 1 . Pregnant . 2 . Presence condition abnormality opinion Investigator would compromise safety patient quality data . 3 . Subject hypersensitivity component vaccine ( e.g. , thimerosal , latex , etc . ) 4 . Subject history severe reaction immunization 5 . Subject history GuillainBarré Syndrome 6 . Subject unable read and/or write due illiteracy physical impairment . 7 . The Investigator concludes anticipated vaccination site ( deltoid area ) suitable adverse event assessment Or legal adult accord local law . Participants NE limit individual age 1969 year due age majority law NE .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Plasma</keyword>
	<keyword>Plasma Donor</keyword>
	<keyword>Plasma Donation</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Td</keyword>
	<keyword>Immunoglobulin</keyword>
	<keyword>Hyper-immunization</keyword>
</DOC>